Application of Fragment-Based de Novo Design to the Discovery of Selective Picomolar Inhibitors of Glycogen Synthase Kinase-3 Beta.

PubWeight™: 0.76^‹?›

🔗 View Article (PMID 27676184)

Published in J Med Chem on September 30, 2016

Authors

Hwangseo Park¹, Yongje Shin²^,3, Jinhee Kim²^,3, Sungwoo Hong²^,3

Author Affiliations

1: Department of Bioscience and Biotechnology, Sejong University , Seoul 143-747, Korea.
2: Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST) , Yuseong-gu, E6-4, Daejeon 305-701, Korea.
3: Center for Catalytic Hydrocarbon Functionalizations, Institute of Basic Science (IBS) , Daejeon 305-701, Korea.

Articles citing this ↘

Anticancer activity of a novel small molecule tubulin inhibitor STK899704. PLoS One (2017) 0.75

Articles by these authors ⇆

Discovery of picomolar ABL kinase inhibitors equipotent for wild type and T315I mutant via structure-based de novo design. J Am Chem Soc (2013) 0.76

Computational design and discovery of nanomolar inhibitors of IκB kinase β. J Am Chem Soc (2015) 0.76